The Patent Finder

Solstice Neurosciences, LLC

Also on record
Records under this name other than patents Solstice Neurosciences, LLC holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Back to Solstice Neurosciences, LLC

PatentTitleStatus Expires Confidence
US 8,173,138Stable liquid formulations of botulinum toxin
Lapsed on the fee record
Ended May 8, 2020 · From the USPTO record
Lapsed on the fee recordEnded May 8, 2020From the USPTO record
US 6,290,961Method for treating dystonia with botulinum toxin type B
Term ended
Term ended Jan 24, 2020 · From the USPTO record
Term endedTerm ended Jan 24, 2020From the USPTO record
US 7,211,261Stable liquid formulations of botulinum toxin
Term ended
Term ended Sep 9, 2019 · From the USPTO record
Term endedTerm ended Sep 9, 2019From the USPTO record
US 6,011,761Downloading compressed audio data from a server and detecting recording inhibiting information
Term ended
Term ended Jun 19, 2018 · From the USPTO record
Term endedTerm ended Jun 19, 2018From the USPTO record
US 6,887,476Method for treating pain with botulinum toxin type B
Term ended
Term ended Mar 30, 2015 · From the USPTO record
Term endedTerm ended Mar 30, 2015From the USPTO record
US 6,645,496Method for treating tardive dyskinesia with Botulinum toxin type B
Term ended
Ended no later than Mar 29, 2015 · From the USPTO record
Term endedEnded no later than Mar 29, 2015From the USPTO record
US 6,861,058Method for treating essential tremor with botulinum toxin type B
Term ended
Term ended Mar 16, 2015 · From the USPTO record
Term endedTerm ended Mar 16, 2015From the USPTO record
US 6,841,156Method for treating muscle spasm with botulinum toxin type B
Term ended
Term ended Apr 24, 2014 · From the USPTO record
Term endedTerm ended Apr 24, 2014From the USPTO record
US 6,632,433Method for treating cervical dystonia with botulinum toxin type B
Term ended
Ended no later than Feb 18, 2014 · From the USPTO record
Term endedEnded no later than Feb 18, 2014From the USPTO record
US 6,872,397Method for treating neuromuscular disorders and conditions with botulinum toxin types A and B
Term ended
Term ended Jun 10, 2013 · From the USPTO record
Term endedTerm ended Jun 10, 2013From the USPTO record
10 of 11 patents shown.
Pro members see all 11.
Pro members: see all 11 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited